Organization Chart for NIDA, link below graphic for description

Office of the Director

Nora D. Volkow, M.D.

David Shurtleff, Ph.D.
Acting Deputy Director

Mary Affeldt, MSM
Associate Director for Management & Operations

Office of Management

Mary Affeldt, MSM

Office of Extramural Affairs

Teresa Levitin, Ph.D.

Office of Science Policy and Communications

Susan Weiss, Ph.D.
Acting Director

Division of Clinical Neuroscience and Behavioral Research

Joseph Frascella, Ph.D.

Division of Epidemiology, Services and Prevention Research

Wilson M. Compton, M.D., M.P.E.

Intramural Research Program

Antonello Bonci, M.D.
Scientific Director

Center for the Clinical Trials Network

Betty Tai, Ph.D.

Division of Basic Neurosciences and Behavioral Research

Joni Rutter, Ph.D.
Acting Director

Division of Pharmacotherapies and Medical Consequences of Drug Abuse

Phil Skolnick, Ph.D., D.Sc.

Go Back To: Fiscal Year 2012 Budget Information - Congressional Justification for National Institute on Drug Abuse